SAN

82.74

+1.24%↑

UCB

259.2

+2.33%↑

SHL.DE

36.15

+0.47%↑

ARGX

620

+1.71%↑

VIE

32.66

+0.93%↑

SAN

82.74

+1.24%↑

UCB

259.2

+2.33%↑

SHL.DE

36.15

+0.47%↑

ARGX

620

+1.71%↑

VIE

32.66

+0.93%↑

SAN

82.74

+1.24%↑

UCB

259.2

+2.33%↑

SHL.DE

36.15

+0.47%↑

ARGX

620

+1.71%↑

VIE

32.66

+0.93%↑

SAN

82.74

+1.24%↑

UCB

259.2

+2.33%↑

SHL.DE

36.15

+0.47%↑

ARGX

620

+1.71%↑

VIE

32.66

+0.93%↑

SAN

82.74

+1.24%↑

UCB

259.2

+2.33%↑

SHL.DE

36.15

+0.47%↑

ARGX

620

+1.71%↑

VIE

32.66

+0.93%↑

Search

Syensqo SA

Fermé

49.34 0.65

Résumé

Variation du prix de l'action

24h

Actuel

Min

48.45

Max

49.78

Chiffres clés

By Trading Economics

Revenu

-204M

-164M

Ventes

-229M

1.3B

Rendement du dividende

3.72

Marge bénéficiaire

-12.34

Employés

13,000

EBITDA

44M

343M

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

3.72%

2.52%

Prochains Résultats

15 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-3.4B

4.6B

Ouverture précédente

48.69

Clôture précédente

49.34

Syensqo SA Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

31 mars 2026, 23:31 UTC

Actions en Tendance

Stocks to Watch: Nike, RH, NCino

31 mars 2026, 22:35 UTC

Résultats

Nike Guides for Sales Declines Ahead as Turnaround Plan Hits Snags -- 2nd Update

1 avr. 2026, 00:00 UTC

Acquisitions, Fusions, Rachats

The Year Is Off to the Strongest Start for Big Deals Ever -- WSJ

31 mars 2026, 23:50 UTC

Acquisitions, Fusions, Rachats

Nxera Pharma: Partner Centessa Pharmaceuticals to Be Acquired by Lilly >LLY 4565.TO

31 mars 2026, 23:43 UTC

Market Talk

Nikkei May Rise on Hopes for Iran War Ending Soon -- Market Talk

31 mars 2026, 23:33 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher on Signs of De-Escalating Middle East Tensions -- Market Talk

31 mars 2026, 23:21 UTC

Résultats

Nike Stock Slides on Tariff Impact Despite Earnings Beat; Turnaround Continues -- Barrons.com

31 mars 2026, 23:14 UTC

Market Talk
Résultats

Nike CEO Says Turnaround is Taking Longer Than He'd Like -- Market Talk

31 mars 2026, 23:12 UTC

Market Talk

Aurelia's Cash Flow Strength Highlighted by New Financing Deal -- Market Talk

31 mars 2026, 22:36 UTC

Résultats

China Vanke 2025 Loss Widens >000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke: Increase in Inventory Impariment Provision Among Factors Weighing On Results>000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke 2025 Loss CNY88.56B Vs. Loss CNY49.48B >000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke: Will Take Time to Resolve Issues Caused by High Debt Levels>000002.SZ

31 mars 2026, 22:36 UTC

Résultats

China Vanke 2025 Rev CNY233.43B Vs. CNY343.18B >000002.SZ

31 mars 2026, 21:46 UTC

Acquisitions, Fusions, Rachats

Big Drug Companies Hunting for Deals Are Lowering Their Sights -- WSJ

31 mars 2026, 21:36 UTC

Market Talk

West African Resources's Costs Higher Than Bull Expected -- Market Talk

31 mars 2026, 21:35 UTC

Résultats

Nike Expects China Sales Down 20% in 4Q, CFO Says

31 mars 2026, 21:35 UTC

Résultats

Nike Expects Modest Growth in North America, Offset by Declines in China, Converse Brand in 4Q, CFO Says

31 mars 2026, 21:35 UTC

Résultats

Nike Forecasts 4Q Sales Down 2% to 4%, CFO Says

31 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Biotechs Are a Healthy Growth Bet Thanks to M&A and New Drugs -- Barrons.com

31 mars 2026, 21:33 UTC

Résultats

Nike Expects Sales Down Low-Single Digits From Now Through End of Calendar Year, CFO Says

31 mars 2026, 21:32 UTC

Résultats

Nike Expects 1Q to Be Final Quarter Where Tariffs Continue to Be Year-Over-Year Headwind to Margins, CFO Says

31 mars 2026, 21:28 UTC

Résultats

Nike Expects to End 4Q With Elevated Inventory, CFO Says

31 mars 2026, 21:26 UTC

Résultats

Nike Increasingly Confident It Will Return to Balanced Growth in North America in Direct, Wholesale Channels, CFO Says

31 mars 2026, 21:25 UTC

Résultats

Nike Expects Supply-Chain Changes to Pay Off Starting in Fiscal 2027, CFO Says

31 mars 2026, 21:24 UTC

Market Talk
Résultats

Nike: Turnaround Plan Progressing at Different Rates -- Market Talk

31 mars 2026, 21:22 UTC

Résultats

Nike CFO Expects Football Training and Basketball Will Return to Growth Over Next Few Quarters

31 mars 2026, 21:22 UTC

Résultats

Nike's Sportswear Business Declined Low-Double Digits in 3Q, CFO Says

31 mars 2026, 21:21 UTC

Résultats

Nike's Digital Channel Still Too Promotional, CFO Says

31 mars 2026, 21:20 UTC

Résultats

Nike CEO: Converse Remains Important to Portfolio

Comparaison

Variation de prix

Syensqo SA prévision

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Syensqo SA

Syensqo SA/NV operates as a science company worldwide. It operates through Materials, and Consumer & Resources segments. The company offers amine ether, amines, fatty amines, and specialty amines; antioxidants and stabilizers; composites; flavors and fragrances, such as vanillin, ethylvanillin, natural vanillin, and cyclopentanone; lithium salts, lithium cryolite, and lithium chemicals; diphenols and hydrocarbon monomers; and phosphorus specialties. It also provides biobased polymers, inverse emlusion polymers, monomers, specialty monomers, and synthetic polymers; solvents, including green solvents, flame retardants, and hydrocarbon; specialty chemicals; specicalty polymers comprising aromatic polyamides, aromatics, sulfones, fluorinated fluids, fluoropolymers, high performance polyester, polyethylene, polyolefin, and polyvinylidene chloride; and amphoteric, anionic, blend, cationic, and non-ionic surfactants. The company's products are used for transportation, aerospace, agro and feed, automotive, building, chemical, consumer goods, electronics, environment and energy, food, healthcare, home personal care, industrial, mining, and oil and gas markets. Syensqo SA/NV was founded in 1863 and is headquartered in Brussels, Belgium.
help-icon Live chat